WebJeff joined SAGE as CEO in 2013 and has more than 20 years of experience on both the scientific and business sides of the pharmaceutical and healthcare industries, particularly in the CNS field. Before joining the SAGE team, Jeff served as President of the Regenerative Medicine Division of Shire plc and previously as Senior Vice President of Research and … Web16 dic 2024 · Jeff Jonas, Sage’s CEO since 2013, will remain with the company as chief innovation officer. The official CEO handoff took place on Tuesday and was made public …
Digital Therapeutics Foto e immagini stock - Getty Images
Web22 mar 2024 · To be marketed as Zulresso, it’s the first drug developed by and approved from Sage Therapeutics of Cambridge, Mass. Jeff Jonas, Sage’s CEO, recently chatted … Web10 nov 2024 · Jonas brings with him more than 25 years of experience in drug development and discovery across multiple therapeutic areas in the pharmaceutical and healthcare industries. Dr. Jonas most... seismic map of nepal
Sage CEO Jeff Jonas leaves his post exechange
Web12 lug 2024 · SAGE +0.32 (+0.74%) Share Mad Money with Jim Cramer Depression should be treated like a broken leg or a seizure, says CEO of development-stage biotech Sage Therapeutics Jim Cramer sits down... WebOn this week’s Tech Nation, it’s about developing medicines which enable the body to heal itself. First up, treating depression in a whole new way … and rapidly. Dr. Jeff Jonas, the Chief Innovation Officer and Director of Sage Therapeutics, talks about their drug Zuranolone, nearing the end of its drug approval journey. Web22 ott 2024 · Sage Therapeutics Announces Chief Executive Jeff Jonas to Undergo Scheduled Medical Procedure. CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Today, … seismic map of nz